Ann Malone Berger

Ann Malone Berger

Auto-generated profile, based on publicly available information

Ann Malone Berger

College of Nursing, University of Nebraska Medical Center, Omaha, Nebraska 68198-5330, USA

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2012 in Cancer
Verified
Journal Article
Closed access
PDF file
ABAnn M. Berger
Ann M. Berger
LGLynn H. Gerber
Lynn H. Gerber
DMDeborah K. Mayer
Deborah K. Mayer

1 November 2005 in Oncology Nursing Forum
Verified
Journal Article
Closed access
PDF file
ABAnn M. Berger
Ann M. Berger
KPKathy P. Parker
Kathy P. Parker
SYStacey Young-McCaughan
Stacey Young-McCaughan
GMGail A. Mallory
Gail A. Mallory
ABAndrea M. Barsevick
Andrea M. Barsevick
MHMartica Hall
Martica Hall
To review the state of the science on sleep/wake disturbances in people with cancer and their caregivers. Published articles, books and book chapters, conference proceedings, and MEDLINE, the Cumulative Index to Nursing and Allied Health Literature, PsycINFO, and the Cochrane Library computerized databases. Scientists have initiated studies on the prevalence of sleep/wake disturbances and the etiology of sleep disturbances specific to cancer. Measurement has been limited by lack of clear definitions of sleep/wake variables, use of a variety of instruments, and inconsistent reporting of sleep parameters. Findings related to use of nonpharmacologic interventions were limited to 20 studies, and the quality of the evidence remains poor. Few pharmacologic approaches have been studied, and evidence for use of herbal and complementary supplements is almost nonexistent. Current knowledge indicates that sleep/wake disturbances are prevalent in cancer populations. Few instruments have been validated in this population. Nonpharmacologic interventions show positive outcomes, but design issues and small samples limit generalizability. Little is known regarding use of pharmacologic and herbal and complementary supplements and potential adverse outcomes or interactions with cancer therapies. All patients and caregivers need initial and ongoing screening for sleep/wake disturbances. When disturbed sleep/wakefulness is evident, further assessment and treatment are warranted. Nursing educational programs should include content regarding healthy and disrupted sleep/wake patterns. Research on sleep/wake disturbances in people with cancer should have high priority.

1 August 2008 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
ABAnn M. Berger
Ann M. Berger
KWKimberly K. Wielgus
Kimberly K. Wielgus
SYStacey Young-McCaughan
Stacey Young-McCaughan
PFPatricia Fischer
Patricia Fischer
LFLynne Farr
Lynne Farr
KLKathryn A. Lee
Kathryn A. Lee

1 April 2007 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
ABAnn M. Berger
Ann M. Berger
LFLynne A. Farr
Lynne A. Farr
BKBrett R. Kuhn
Brett R. Kuhn
PFPatricia Fischer
Patricia Fischer
SASangeeta Agrawal
Sangeeta Agrawal

20 May 2013 in Cancer
Verified
Journal Article
Closed access
PDF file
OMOllie Minton
Ollie Minton
ABAnn Berger
Ann Berger
ABAndrea Barsevick
Andrea Barsevick
FCFiona Cramp
Fiona Cramp
MGMartine Goedendorp
Martine Goedendorp
PSPatrick C. Stone
Patrick C. Stone

11 March 2015 in CA: A Cancer Journal for Clinicians
Verified
Journal Article
Open access
PDF file
ABAnn M. Berger
Ann M. Berger
SMSandra A. Mitchell
Sandra A. Mitchell
PJPaul B. Jacobsen
Paul B. Jacobsen
WPWilliam F. Pirl
William F. Pirl
Answer questions and earn CME/CNE Evidence regarding cancer‐related fatigue (fatigue) has accumulated sufficiently such that recommendations for screening, evaluation, and/or management have been released recently by 4 leading cancer organizations. These evidence‐based fatigue recommendations are available for clinicians, and some have patient versions; but barriers at the patient, clinician, and system levels hinder dissemination and implementation into practice. The underlying biologic mechanisms for this debilitating symptom have not been elucidated completely, hindering the development of mechanistically driven interventions. However, significant progress has been made toward methods for screening and comprehensively evaluating fatigue and other common symptoms using reliable and valid self‐report measures. Limited data exist to support the use of any pharmacologic agent; however, several nonpharmacologic interventions have been shown to be effective in reducing fatigue in adults. Never before have evidence‐based recommendations for fatigue management been disseminated by 4 premier cancer organizations (the National Comprehensive Cancer, the Oncology Nursing Society, the Canadian Partnership Against Cancer/Canadian Association of Psychosocial Oncology, and the American Society of Clinical Oncology). Clinicians may ask: Are we ready for implementation into practice? The reply: A variety of approaches to screening, evaluation, and management are ready for implementation. To reduce fatigue severity and distress and its impact on functioning, intensified collaborations and close partnerships between clinicians and researchers are needed, with an emphasis on system‐wide efforts to disseminate and implement these evidence‐based recommendations. CA Cancer J Clin 2015;65: 190–211. © 2015 American Cancer Society.